Treatment patterns and outcomes in older patients with mantle cell lymphoma in an Asian population

被引：0
|
作者：
Yang, X. [1 ]
Khoo, L. P. [2 ]
Chang, E. W. Y. [2 ]
Yang, V. S. [2 ]
Poon, E. Y. L. [2 ]
Somasundaram, N. [2 ]
Farid, M. [2 ]
Tang, T. P. L. [2 ]
Tao, M. [2 ]
Lim, S. T. [2 ]
Chan, J. Y. [2 ]
机构：
[1] Natl Univ Singapore, Singapore, Singapore
[2] Natl Canc Ctr Singapore, Med Oncol, Singapore, Singapore
来源：
ANNALS OF ONCOLOGY | 2020年 / 31卷
基金：
英国医学研究理事会;
关键词：
D O I：
10.1016/j.annonc.2020.10.253
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
259O
引用
收藏
页码：S1344 / S1344
页数：1
相关论文
共 50 条
  • [21] Advancing treatment in patients with mantle cell lymphoma
    不详
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2021, 14 (SUPPL 1) : S15 - S17
  • [22] Treatment for patients with indolent and mantle cell lymphoma
    Yamaguchi, Tsukasa
    Morita, Tomohiro
    Takahashi, Yukie
    Tsuda, Kenji
    Mori, Jinichi
    LANCET, 2013, 382 (9898): : 1094 - 1095
  • [23] Treatment of Younger Patients With Mantle Cell Lymphoma
    Harel, Stephanie
    Delarue, Richard
    Ribrag, Vincent
    Dreyling, Martin
    Hermine, Olivier
    SEMINARS IN HEMATOLOGY, 2011, 48 (03) : 194 - 207
  • [24] Treatment of Elderly Patients With Mantle Cell Lymphoma
    Kluin-Nelemans, Hanneke C.
    Doorduijn, Jeanette K.
    SEMINARS IN HEMATOLOGY, 2011, 48 (03) : 208 - 213
  • [25] Clinical characteristics and outcomes of 476 mantle cell lymphoma patients aged 80 years and older
    Pahnke, Simon
    Abalo, Kossi D.
    Ekberg, Sara
    Albertsson-Lindblad, Alexandra
    Smedby, Karin E.
    Jerkeman, Mats
    Glimelius, Ingrid
    BLOOD CANCER JOURNAL, 2024, 14 (01):
  • [26] Survival Outcomes of Rural Patients with Mantle Cell Lymphoma
    Rubnitz, Zach
    Vardell, Victoria A.
    Fitzgerald, Lindsey
    Bock, Allison M.
    Shah, Harsh
    Hu, Boyu
    Stephens, Deborah M.
    Ermann, Daniel A.
    BLOOD, 2023, 142
  • [27] Real-World Practice Patterns and Outcomes Following Bruton Tyrosine Kinase Inhibitors (BTKi) in Older Patients with Mantle Cell Lymphoma (MCL): A Population-Based Analysis
    Di, Mengyang
    Long, Jessica B.
    Kothari, Shalin K.
    Sethi, Tarsheen
    Zeidan, Amer M.
    Podoltsev, Nikolai A.
    Shallis, Rory Michael
    Wang, Rong
    Stempel, Jessica M.
    Ma, Xiaomei
    Huntington, Scott F.
    BLOOD, 2022, 140 : 10904 - 10906
  • [28] Older patients with mantle cell lymphoma (MCL): Practice patterns and predictors of survival in the rituximab era.
    Karmali, Reem
    Switchenko, Jeffrey M.
    Goyal, Subir
    Bachanova, Veronika
    Gerson, James
    Barta, Stefan K.
    Danilov, Alexey Valeryevich
    Grover, Natalie Sophia
    Epperla, Narendranath
    Burkart, Madelyn
    Sawalha, Yazeed
    Ghosh, Nilanjan
    Bond, David Alan
    Maddocks, Kami J.
    Badar, Talha
    Fenske, Timothy
    Guo, Jin
    Malecek, Mary-Kate
    Martin, Peter
    Cohen, Jonathon Brett
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [29] Retrospective analysis of treatment patterns and outcomes with subcutaneous (SQ) bortezomib (BTZ) in patients (pts) with relapsed mantle cell lymphoma (MCL).
    Bonthapally, Vijayveer
    Lafeuille, Marie-Helene
    Fortier, Jonathan
    Duh, Mel Sheng
    Ng, Yvette
    Van De Velde, Helgi
    Niculescu, Liviu
    Ma, Esprit
    Goy, Andre
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [30] Evolving treatment patterns and improved outcomes in relapsed/refractory mantle cell lymphoma: a prospective cohort study
    Bock, Allison M.
    Gile, Jennifer J.
    Larson, Melissa C.
    Poonsombudlert, Kittika
    Tawfiq, Reema K.
    Maliske, Seth
    Maurer, Matthew J.
    Kabat, Brian F.
    Paludo, Jonas
    Inwards, David J.
    Ayyappan, Sabarish
    Link, Brian K.
    Ansell, Stephen M.
    Habermann, Thomas M.
    Witzig, Thomas E.
    Nowakowski, Grzegorz S.
    Cerhan, James R.
    Farooq, Umar
    Wang, Yucai
    BLOOD CANCER JOURNAL, 2023, 13 (01)
12345